Companies: 10,795·Total market cap: $144.5T
Generex Biotechnology Corporation

Generex Biotechnology Corporation

GNBTOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$0
P/E Ratio—
52W High—
52W Low—
Overview

Generex Biotechnology Corporation (GNBT) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001059784 · GNBT · OTC · as of Jun 9, 2026

Filing snapshot

872
Total Filings
SEC STAFF ACTION
Latest Form
2023-10-10
Most Recent
1998
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001059784 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2020-11-13
Fiscal Year End
Nov 13, 2020
Accession No.
0001607062-20-000327
Primary Document
gnbt073120form10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001059784 · Accession 0001607062-20-000327

Latest Key Filings

10-QQuarterly Report
10-Q
2021-06-21
View 10-Q on SEC
8-KCurrent Report
8-K
2021-07-23Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SEC STAFF ACTIONSEC STAFF ACTION
SEC STAFF ACTION
2023-10-10
View
SEC STAFF ACTIONSEC STAFF ACTION
SEC STAFF ACTION
2023-10-10
View
REVOKEDREVOKED
REVOKED
2023-01-27
View
NT 10-KNT 10-K
NT 10-K
2021-11-01
View
8-KCurrent Report
8-K
2021-07-23
View
8-KCurrent Report
8-K
2021-07-21
View
10-QQuarterly Report
10-Q
2021-06-21
View
NT 10-QNT 10-Q
NT 10-Q
2021-06-14
View
8-KCurrent Report
8-K
2021-05-12
View
8-KCurrent Report
8-K
2021-04-29
View
8-KCurrent Report
8-K
2021-04-27
View
10-QQuarterly Report
10-Q
2021-03-17
View
8-KCurrent Report
8-K
2021-02-23
View
8-KCurrent Report
8-K
2021-02-19
View
8-KCurrent Report
8-K
2021-02-10
View
Showing 1–15 of 737 filingsForm 4 / 144 hidden· 872 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001059784  |  Exchange: OTC · Healthcare

Generex Biotechnology Corporation (OTC: GNBT) has submitted 872 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1998. As a Healthcare sector company with CIK 0001059784, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Generex Biotechnology Corporation's most comprehensive regulatory disclosure. The most recent Generex Biotechnology Corporation 10-K was filed on 2020-11-13 for fiscal year ending 2020. Historical GNBT 10-K annual reports are available from 1998 through 2020.

Investors researching Generex Biotechnology Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
PPCB SEC Filings →TCON SEC Filings →PRED SEC Filings →NVTAQ SEC Filings →NXNN SEC Filings →HCLC SEC Filings →CRXTQ SEC Filings →HGENQ SEC Filings →
→ GNBT Financials→ GNBT Earnings→ GNBT Insider Trades

Frequently Asked Questions

GNBT SEC Filings · 8 questions

Generex Biotechnology Corporation (GNBT) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 872 filings and access original documents at no cost. Generex Biotechnology Corporation's CIK is 0001059784.

GNBT SEC filingsGenerex Biotechnology Corporation SEC documentsfind GNBT 10-K